✦ LIBER ✦

Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant

✍ Scribed by Stefan Siebert; Nick Amos; Ceri A. Fielding; Eddie C. Y. Wang; Ivona Aksentijevich; Bryan D. Williams; Paul Brennan

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 183 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.20955

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Shedding of mutant tumor necrosis factor

Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor–associated periodic syndrome: Differences between cell types

✍ Mary L. Huggins; Paul M. Radford; Richard S. McIntosh; Susan E. Bainbridge; Pete 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## Objective To investigate the effect of mutations in tumor necrosis factor receptor superfamily 1A (TNFRSF1A) on the ability of the receptors to be cleaved from the cell surface upon stimulation. The mutations we studied are associated with clinically distinct forms of TNF receptor–a

Differentiation induction by a tumor-nec

Differentiation induction by a tumor-necrosis-factor mutant 471 in human myelogenous leukemic cells via tumor-necrosis-factor receptor-p55

✍ Tsutomu Sato; Naoki Watanabe; Naofumi Yamauchi; Hiroyoshi Sasaki; Daisuke Kobaya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 168 KB 👁 1 views

The present study examined differentiation-inducing activity by various tumor-necrosis-factor(TNF) mutants against the human leukemic cell lines HL-60 and U-937. Mutant TNF 471, from which 7 N-terminal amino acids of native TNF were deleted and Pro 8 , Ser 9 and Asp 10 were replaced by Arg, Lys and

A tumor necrosis factor-induced model of

A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice

✍ George Kassiotis; Jan Bauer; Katerina Akassoglou; Hans Lassmann; George Kollias; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

Blocking ERK-1/2 reduces tumor necrosis

Blocking ERK-1/2 reduces tumor necrosis factor α–induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A

✍ Hubert Marotte; Salahuddin Ahmed; Jeffrey H. Ruth; Alisa E. Koch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

Replication of the tumor necrosis factor

Replication of the tumor necrosis factor receptor−associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study

✍ F. A. S. Kurreeman; D. Rocha; J. Houwing-Duistermaat; S. Vrijmoet; V. H. Teixeir 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

A novel mutation in the third extracellu

A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever

✍ Hanna Nevala; Leena Karenko; Susanna Stjernberg; Maria Raatikainen; Hanna Suomal 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 1 views